(Q34029290)

English

Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

double-blind clinical trial

1 reference

based on heuristic

inferred from title

Haya Ascher-Svanum

1

object named as

Haya Ascher-Svanum

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Fangyi Zhao

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Holland C Detke

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Allen W Nyhuis

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Anthony H Lawson

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Virginia L Stauffer

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

William Montgomery

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Michael M Witte

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

David P McDonnell

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

23 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

152

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187740

5 July 2018

The PANSS should be rescaled

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187740

5 July 2018

Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187740

5 July 2018

Should the PANSS be rescaled?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187740

5 July 2018

Trajectories and antecedents of treatment response over time in early-episode psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187740

5 July 2018

Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187740

5 July 2018

A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187740

5 July 2018

Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187740

5 July 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187740

5 July 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187740

5 July 2018

Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-152

21 January 2018

Evidence for onset of antipsychotic effects within the first 24 hours of treatment

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-152

21 January 2018

Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-152

21 January 2018

Early Prediction of Antipsychotic Response in Schizophrenia

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-152

21 January 2018

Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-152

21 January 2018

Optimal thresholds of early response to atypical antipsychotics: application of signal detection methods

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-152

21 January 2018

Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-152

21 January 2018

Elaboration on the early-onset hypothesis of antipsychotic drug action: treatment response trajectories

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-152

21 January 2018

Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187740

29 October 2018

An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187740

29 October 2018

Longer time to antipsychotic treatment discontinuation for any cause is associated with better functional outcomes for patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187740

29 October 2018

The effects of olanzapine on the 5 dimensions of schizophrenia derived by factor analysis: combined results of the North American and international trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3187740

29 October 2018

Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-152

21 January 2018

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21943257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent vs maintenance medication in schizophrenia. Two-year results

1 reference

https://pubmed.ncbi.nlm.nih.gov/21943257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early prediction of antipsychotic nonresponse among patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21943257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-244X-11-152

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34029290&oldid=2196142749"